Home›Stock Screener›Jeevan Scientific Technology

Jeevan Scientific Technology Share Price Today | Stock Price & Jeevan Scientific Technology Share Screener

JSTL Healthcare Services
Live Share Price BSE
₹81.96
▼ -6.03 (-6.85%)
2026-11-20 00:00:00

As of November 20, 2026, the live Jeevan Scientific Technology share price (BSE: JSTL) is ₹81.96, down 6.85% from the previous close, with shares trading between ₹80.30 and ₹88.00 in today's trading session, and a 52-week range of ₹59.49–₹90.30. Track JSTL company valuation to gauge the company's total market size. Use the Jeevan Scientific Technology stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Jeevan Scientific Technology opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹22 and net income of ₹2, with EBITDA of ₹5, an operating margin of 20.0% and a profit margin of 9.1%.

Jeevan Scientific Technology Market Cap ₹180.90 Cr.
JSTL P/E Ratio (TTM) 22.60
Jeevan Scientific Technology P/B Ratio 2.35
EPS (TTM) ₹0.52
Dividend Yield 1.33%
Debt to Equity 0.35
JSTL 52 Week High ₹90.30
Jeevan Scientific Technology 52 Week Low ₹59.49
Operating Margin 20.00%
Profit Margin 9.09%
JSTL Revenue (TTM) ₹22.00
EBITDA ₹5.00
Net Income ₹2.00
Total Assets ₹107.00
Total Equity ₹72.00

Jeevan Scientific Technology Share Price Chart

Track the current stock price of Jeevan Scientific Technology with an interactive chart. Analyse JSTL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Jeevan Scientific Technology stock quote in one place.

The quote of ₹81.96 sits between the 52-week low of ₹59.49 and the 52-week high of ₹90.30, and the latest session moved -6.85% from the previous close.

Jeevan Scientific Technology Company Profile - Fundamental Screener

Screen Jeevan Scientific Technology company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JSTL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE237B01018.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE237B01018

Jeevan Scientific Technology Balance Sheet Screener

Screen JSTL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹107, up from ₹78 in 2025.

Latest statistics put total assets at ₹107 and shareholder funds at ₹72, with a leverage ratio of 0.35.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 107 78 68 66 78 66 54 61 49 31
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 41 35 27 25 19 27 31 33 28 16

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 14 16 10 6 5 8 8 8 10 5
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 72 50 49 48 51 35 23 32 22 17
Share Capital 20 16 16 16 15 15 15 15 12 9
Reserves & Surplus 52 34 33 33 35 20 8 17 7 3

Jeevan Scientific Technology Income Statement Screener - Profit & Revenue Analysis

Screen Jeevan Scientific Technology income statement and profit fundamentals. Analyze JSTL quarterly results. Jeevan Scientific Technology reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹22 and net profit was ₹2, equal to earnings per unit of ₹0.92, at an operating margin of 20%.

In that period expenses were ₹17, interest cost ₹0 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹19 and net profit of ₹1.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 22 19 24 10 9 13 19 11 13 12 13 8 11 8 10
Expenses 17 15 18 10 11 10 14 10 10 9 10 9 8 8 9

Operating Costs and Margins

EBITDA 5 3 6 0 -1 2 5 1 3 3 2 -1 2 1 1
Operating Profit % 20.00% 16.00% 25.00% -4.00% -20.00% 17.00% 27.00% 9.00% 25.00% 22.00% 17.00% -13.00% 20.00% 7.00% 10.00%
Depreciation 2 2 2 2 2 2 2 2 2 2 2 1 2 1 1
Interest 0 0 1 1 1 1 1 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 3 1 4 -3 -4 0 3 -1 2 1 0 -3 1 -1 -1
Tax 1 0 1 -1 -1 0 1 0 1 1 0 0 0 0 0
Net Profit 2 1 3 -1 -3 0 2 -1 1 0 0 -2 1 -1 -1
EPS 0.92 0.44 1.45 -0.81 -2.03 0.01 1.52 -0.47 0.66 0.16 0.03 -1.51 0.33 -0.39 -0.31

Jeevan Scientific Technology Cash Flow Screener - Liquidity Fundamentals

Screen JSTL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹10.

Over the same period, investing activities used ₹16 and financing activities provided ₹5.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 10 3 -6 20 5 0 4 6 -6 4
Investing Activities -16 -12 -7 -1 -1 -2 -8 -14 -9 -4

Financing and Net Cash

Financing Activities 5 2 -10 6 0 0 6 10 15 0
Net Cash Flow 0 -6 -23 24 4 -2 2 1 0 0

Jeevan Scientific Technology Shareholding Pattern Screener

See Jeevan Scientific Technology shareholding pattern with promoter, FII, and DII holdings. Check Jeevan Scientific Technology promoter holding and ownership changes for JSTL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 30.25%, foreign institutions 0.00%, domestic institutions 0.00% and the public 55.79%, spread across 5,053 shareholders.

The shareholder count was 5,053 in 2026-Mar, compared with 4,966 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 30.25% 30.25% 30.00% 38.05% 38.05% 38.05% 38.05% 38.70%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 55.79% 55.80% 57.17% 42.99% 42.75% 42.76% 46.56% 45.50%
Other Holding 13.96% 13.95% 12.83% 18.96% 19.21% 19.19% 15.39% 15.80%
Shareholder Count 5,053 4,966 4,971 5,497 5,460 5,444 5,159 5,749

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Jeevan Scientific Technology. Jeevan Scientific Technology dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹1.20 2.38%
2021-March ₹0.50 0.38%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Jeevan Scientific Technology Stock Index Membership - Nifty & Sensex

See which indices include Jeevan Scientific Technology stock. Check JSTL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Jeevan Scientific Technology is not part of any tracked indices.
Only major market indices are tracked in our system.

Jeevan Scientific Technology Market Events Screener - Corporate Actions

Get Jeevan Scientific Technology corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Jeevan Scientific Technology stock events that may affect JSTL share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 11, 2026, with a record date of November 11, 2026.

It is followed by Annual General Meeting dated September 25, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-11 2026-11-11 Quarterly Result Announcement NA -2.65%
2026-09-25 2026-09-25 Annual General Meeting NA -1.85%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -2.40%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 1.88%
2026-02-11 2026-02-11 Quarterly Result Announcement NA 0.00%
2025-11-12 2025-11-12 Extraordinary General Meeting NA 7.67%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -4.42%
2025-09-27 2025-09-27 Annual General Meeting NA -8.88%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 7.49%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.73%
2025-03-27 2025-03-27 Extraordinary General Meeting NA -3.79%
2025-02-06 2025-02-06 Quarterly Result Announcement NA 0.42%
2024-11-08 2024-11-08 Quarterly Result Announcement NA -0.11%
2024-08-09 2024-08-09 Annual General Meeting NA 11.55%
2022-09-21 2022-09-23 Dividend ₹ 1.20 /share -20.11%

Jeevan Scientific Technology Competitors Screener - Peer Stocks Comparison

Screen JSTL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,114 53.90 25,420 15.58% 2,003 64.36
Max Healthcare Institute 98,295 71.20 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 90,925 104.20 10,521 25.80% 917 58.01
Aster DM Quality Care 65,375 116.10 4,769 11.25% 427 61.53
Fortis Healthcare 60,638 57.00 9,179 16.93% 1,064 56.49
Narayana Hrudayalaya 38,733 45.00 7,996 43.43% 811 60.17
Global Health 38,546 62.80 4,509 19.56% 554 63.26
Dr. Lal Path Labs 33,582 57.20 2,864 12.11% 510 57.81
Krishna Institute of Medical Sciences 32,061 163.00 3,931 28.16% 242 65.46
Syngene International 17,810 95.70 3,809 2.56% 317 66.04

Jeevan Scientific Technology Company Announcements - News & Reports Screener

Screen JSTL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 17, 2026 and November 17, 2026.

Date Update Actions
2026-11-17 Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-11-17 Announcement under Regulation 30 (LODR)-Change in Management -
2026-11-17 Board Meeting Outcome for Outcome Of The Board Meeting Held On 11.11.2026 -
2026-11-17 Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2026 -
2026-11-04 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 11-11-2026. -
2026-10-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Closure Of The United States Food And Drug Administration (US FDA) Inspection Of JSTL And Issuance Of The Establishment Inspection Report (EIR) Received By The Company On 30.09.2026 . -
2026-09-29 Closure of Trading Window -
2026-09-25 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-25 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-03 Reg. 34 (1) Annual Report. -
2026-09-03 28Th Annual General Meeting Of The Company Is Schecduled To Be Held On 25.09.2026 At 10:00 A.M. -
2026-08-13 Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-13 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-13 Unaudited Financial Results (Standalone And Consoilidated) For The Quarter Ended 30.06.2026. -
2026-08-13 Board Meeting Outcome for Outcome Of The Board Meeting -
2026-08-10 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13.08.2026. -
2026-08-01 Intimation Of Approval For Addition Of Beds To The Existing Approved Bioavailability/ Bioequivalence Center Of Jeevan Scientific Technology Limiteds Bioavailability/Bioequivalence. -
2026-07-24 Information About The Successful Completion Of USFDA Inspection. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹81.96, within a 52-week range of ₹59.49 to ₹90.30. The P/E ratio is 22.60 and the P/B ratio is 2.35, with earnings per unit of ₹0.52. Market capitalisation stands at ₹180.90 Cr and the dividend yield is 1.33%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 22, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.